STABILE, ARMANDO
 Distribuzione geografica
Continente #
EU - Europa 547
NA - Nord America 278
AS - Asia 86
SA - Sud America 11
AF - Africa 1
OC - Oceania 1
Totale 924
Nazione #
IT - Italia 362
US - Stati Uniti d'America 274
SE - Svezia 123
JP - Giappone 40
CN - Cina 25
TR - Turchia 13
FI - Finlandia 12
DE - Germania 9
FR - Francia 8
BR - Brasile 7
IE - Irlanda 5
IN - India 5
AR - Argentina 3
CA - Canada 3
ES - Italia 3
GB - Regno Unito 3
GR - Grecia 3
LT - Lituania 3
PL - Polonia 3
AT - Austria 2
BG - Bulgaria 2
NL - Olanda 2
NO - Norvegia 2
RU - Federazione Russa 2
SA - Arabia Saudita 2
SK - Slovacchia (Repubblica Slovacca) 2
CZ - Repubblica Ceca 1
DZ - Algeria 1
HK - Hong Kong 1
MX - Messico 1
NZ - Nuova Zelanda 1
PY - Paraguay 1
Totale 924
Città #
New York 80
Milan 47
Ashburn 35
Lawrence 28
Princeton 28
Shanghai 24
Rome 22
Turin 13
Helsinki 12
Palermo 10
Bologna 9
Florence 8
Naples 8
Bari 7
Bursa 7
Falconara Marittima 7
Padova 6
Tokyo 6
Dublin 5
Genoa 5
Lamezia Terme 5
Los Angeles 5
Paris 5
Pune 5
Arcore 4
Montepulciano 4
Aci Sant'antonio 3
Andria 3
Bolzano 3
Buenos Aires 3
Gohongi 3
Istanbul 3
London 3
Paderborn 3
Pavia 3
Shibuya 3
Trieste 3
Ancona 2
Athens 2
Barcelona 2
Bethesda 2
Borås 2
Castel Gandolfo 2
Chiampo 2
Chiyoda-ku 2
Ciserano 2
Cordenons 2
Ferrara 2
Hanawada 2
Imola 2
Jales 2
Kaunas 2
Lecce 2
Messina 2
Miami 2
Modena 2
Moncalieri 2
Niigata 2
Nogara 2
Palhoca 2
Pisa 2
Porto Alegre 2
Quartu Sant'Elena 2
Québec 2
Rimini 2
Sant'Elena 2
Sant'Ilario d'Enza 2
Santeramo in Colle 2
Seattle 2
Sharon 2
Sofia 2
Sommacampagna 2
Syracuse 2
Tangen 2
Tenri 2
Toulon 2
Treviso 2
Tusa 2
Vienna 2
Washington 2
Asunción 1
Bagheria 1
Banská Bystrica 1
Belgorod 1
Bergamo 1
Blida 1
Brescia 1
Campi Bisenzio 1
Cartagena 1
Castel Maggiore 1
Centrale 1
Cervignano del Friuli 1
Chalcis 1
Chiba 1
Chicago 1
Christchurch 1
Council Bluffs 1
Crotone 1
Deiva Marina 1
Diemen 1
Totale 534
Nome #
External Validation of the 2019 Briganti Nomogram for the Identification of Prostate Cancer Patients Who Should Be Considered for an Extended Pelvic Lymph Node Dissection 442
How to optimize follow-up in patients with a suspicious multiparametric MRI and a subsequent negative targeted prostate biopsy. Results from a large, single-institution series 31
Impact of prostate imaging quality (PI-QUAL) score on the detection of clinically significant prostate cancer at biopsy 23
Defining Clinically Meaningful Positive Surgical Margins in Patients Undergoing Radical Prostatectomy for Localised Prostate Cancer 20
Age and gleason score upgrading between prostate biopsy and radical prostatectomy: Is this still true in the multiparametric resonance imaging era? 20
Multiparametric magnetic resonance imaging of the prostate underestimates tumour volume of small visible lesions 18
Combined Use of Prostate-specific Antigen Density and Magnetic Resonance Imaging for Prostate Biopsy Decision Planning: A Retrospective Multi-institutional Study Using the Prostate Magnetic Resonance Imaging Outcome Database (PROMOD) 17
Reply by Authors 17
Risk Stratification of Patients Candidate to Radical Prostatectomy Based on Clinical and Multiparametric Magnetic Resonance Imaging Parameters: Development and External Validation of Novel Risk Groups 17
Can Negative Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography Avoid the Need for Pelvic Lymph Node Dissection in Newly Diagnosed Prostate Cancer Patients? A Systematic Review and Meta-analysis with Backup Histology as Reference Standard 16
Molecular biomarkers in the context of focal therapy for prostate cancer: recommendations of a Delphi Consensus from the Focal Therapy Society 16
Optimizing prostate-targeted biopsy schemes in men with multiple mpMRI visible lesions: should we target all suspicious areas? Results of a two institution series 16
Impact of prostate MRI central review over the diagnostic performance of MRI-targeted biopsy: should we routinely ask for an expert second opinion? 15
Prostate-specific membrane antigen Radioguided Surgery to Detect Nodal Metastases in Primary Prostate Cancer Patients Undergoing Robot-assisted Radical Prostatectomy and Extended Pelvic Lymph Node Dissection: Results of a Planned Interim Analysis of a Prospective Phase 2 Study 15
Assessing the Clinical Value of Positive Multiparametric Magnetic Resonance Imaging in Young Men with a Suspicion of Prostate Cancer 15
Prognostic Implications of Multiparametric Magnetic Resonance Imaging and Concomitant Systematic Biopsy in Predicting Biochemical Recurrence After Radical Prostatectomy in Prostate Cancer Patients Diagnosed with Magnetic Resonance Imaging-targeted Biopsy 15
Interreader variability in prostate MRI reporting using Prostate Imaging Reporting and Data System version 2.1 14
Followup of Men with PI-RADS™ 4 or 5 Abnormality on Prostate Magnetic Resonance Imaging and Nonmalignant Pathological Findings on Initial Targeted Prostate Biopsy. Letter 14
Positive Predictive Value of Prostate Imaging Reporting and Data System Version 2 for the Detection of Clinically Significant Prostate Cancer: A Systematic Review and Meta-analysis 14
Survival after Radical Prostatectomy versus Radiation Therapy in High-Risk and Very High-Risk Prostate Cancer. Letter 13
Medium-term oncological outcomes in a large cohort of men treated with either focal or hemi-ablation using high-intensity focused ultrasonography for primary localized prostate cancer 13
Reducing the Risk of Postoperative Complications After Robot-assisted Radical Prostatectomy in Prostate Cancer Patients: Results of an Audit and Feedback Intervention Following the Implementation of Prospective Data Collection 13
Association between Lesion Location and Oncologic Outcomes after Focal Therapy for Localized Prostate Cancer Using Either High Intensity Focused Ultrasound or Cryotherapy 13
Impact of Early Dorsal Venous Complex Ligation on Urinary Continence Recovery after Robot-assisted Radical Prostatectomy: Results from a Phase 3 Randomized Controlled Trial 12
Predictive value of preoperative neutrophil-to-lymphocyte ratio in localized prostate cancer: results from a surgical series at a high-volume institution 12
Association Between Multiparametric Magnetic Resonance Imaging of the Prostate and Oncological Outcomes after Primary Treatment for Prostate Cancer: A Systematic Review and Meta-analysis 12
Are Urologists Ready for Interpretation of Multiparametric MRI Findings? A Prospective Multicentric Evaluation 11
Prediction of the Need for an Extended Lymphadenectomy at the Time of Radical Cystectomy in Patients with Bladder Cancer 11
Letter - Can micro-ultrasound be the new first-choice test for patients with a suspicion of prostate cancer? 11
Identification of the Optimal Candidates for Nodal Staging with Extended Pelvic Lymph Node Dissection Among Prostate Cancer Patients Who Underwent Preoperative Prostate-specific Membrane Antigen Positron Emission Tomography. External Validation of the Memorial Sloan Kettering Cancer Center and Briganti Nomograms and Development of a Novel Tool 10
Assessing the need for systematic biopsies in addition to targeted biopsies according to the characteristics of the index lesion at mpMRI. Results from a large, multi-institutional database 10
Does previous prostate surgery affect multiparametric magnetic resonance imaging accuracy in detecting clinically significant prostate cancer? Results from a single institution series 10
The Role of Percentage of Prostate-specific Antigen Reduction After Focal Therapy Using High-intensity Focused Ultrasound for Primary Localised Prostate Cancer. Results from a Large Multi-institutional Series 10
Oncologic Surveillance for Variant Histology Bladder Cancer after Radical Cystectomy 10
Metastatic hormone‑sensitive prostate cancer: local treatment strategies 10
Diagnostic Accuracy of Abbreviated Bi-Parametric MRI (a-bpMRI) for Prostate Cancer Detection and Screening: A Multi-Reader Study 10
RE: Retzius Sparing Prostatectomy Effect on Symptomatic Lymphocele Rates 9
Open Versus Robotic Cystectomy: A Propensity Score Matched Analysis Comparing Survival Outcomes 8
The quality of life of children and adolescents with X-linked agammaglobulinemia 6
Variability of mpMRI diagnostic performance according to the upfront individual patient risk of having clinically significant prostate cancer 4
null 1
null 1
Totale 975
Categoria #
all - tutte 7.105
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.105


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20205 2 0 0 0 2 0 0 0 1 0 0 0
2020/20217 0 0 0 0 0 6 0 0 1 0 0 0
2021/2022113 0 11 4 8 8 7 15 14 5 10 17 14
2022/2023341 75 56 22 14 14 55 23 26 15 4 24 13
2023/2024509 12 16 37 47 50 131 43 77 11 80 5 0
Totale 975